REgulatory T Cell Therapy to Achieve Immunosuppression REduction
NCT06552169
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Kidney Transplantation
Interventions
DRUG:
Arm 1: SOC (mTOR + CNI)
BIOLOGICAL:
Arm 2A: TRACT/MONO mTOR
BIOLOGICAL:
Arm 2B: TRACT/MONO CNI
Sponsor
Singulera Therapeutics Inc.
Collaborators
[object Object]